Theralink Technologies Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Revenue	0.64	0.61	0.57	0.51	0.18	-
Revenue Growth (YoY)	16.76%	6.85%	12.32%	178.99%	-	-
Cost of Revenue	0.25	0.2	0.36	0.25	0.1	-
Gross Profit	0.39	0.4	0.2	0.26	0.08	-
Selling, General & Admin	8.1	9.15	11.84	5.82	3.43	1.6
Research & Development	-	-	-	-	-	0.17
Operating Expenses	8.1	9.15	11.84	5.82	3.43	1.77
Operating Income	-7.71	-8.74	-11.64	-5.57	-3.36	-1.77
Interest Expense	-19.61	-16.91	-1.09	-0.12	-0.03	-1.8
Currency Exchange Gain (Loss)	-	-	-	-0.02	0.05	-
Other Non Operating Income (Expenses)	14.07	0.62	-	-	0.01	-5.76
EBT Excluding Unusual Items	-13.26	-25.03	-12.73	-5.71	-3.33	-9.32
Gain (Loss) on Sale of Investments	-0	-0	-0.01	-0	-0.01	-
Gain (Loss) on Sale of Assets	-	-	-	0.01	-	-
Asset Writedown	-0.24	-0.24	-	-	-	-
Other Unusual Items	-	-5.63	-	0.23	0.17	-0.08
Pretax Income	-13.5	-30.91	-12.74	-5.47	-3.17	-9.4
Earnings From Continuing Operations	-13.5	-30.91	-12.74	-5.47	-3.17	-9.4
Net Income	-13.5	-30.91	-12.74	-5.47	-3.17	-9.4
Preferred Dividends & Other Adjustments	-	0.04	0.24	1.17	2.01	-
Net Income to Common	-13.5	-30.95	-12.98	-6.64	-5.18	-9.4
Shares Outstanding (Basic)	6,151	6,151	5,881	5,370	85	0
Shares Outstanding (Diluted)	6,151	6,151	5,881	5,370	85	0
Shares Change (YoY)	2.01%	4.60%	9.53%	6242.72%	17008.05%	-
EPS (Basic)	-0.00	-0.01	-0.00	-0.00	-0.06	-19.00
EPS (Diluted)	-0.00	-0.01	-0.00	-0.00	-0.06	-19.00
Free Cash Flow	-5.12	-5.94	-5.52	-4.92	-4	-1.17
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.05	-2.37
Gross Margin	61.41%	66.70%	36.02%	50.77%	42.47%	-
Operating Margin	-1213.62%	-1440.47%	-2049.64%	-1100.86%	-1852.24%	-
Profit Margin	-2124.13%	-5100.06%	-2285.94%	-1312.94%	-2856.27%	-
Free Cash Flow Margin	-805.21%	-978.62%	-972.22%	-972.43%	-2208.42%	-
EBITDA	-7.51	-8.53	-11.45	-5.38	-3.26	-1.77
D&A For EBITDA	0.2	0.21	0.19	0.19	0.1	0
EBIT	-7.71	-8.74	-11.64	-5.57	-3.36	-1.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.